BRAF testing techniques in the management of patients with advanced malignant melanoma: a real world comparative study

Autor: Colombino M, Rozzo C, Paliogiannis P, Casula M, Manca A, Doneddu V, Fedeli MA, Sini MC, Palomba G, Pisano M, Melanoma Unit of Sassari (MUS), Italian Association for Cancer Research (AIRC) Study Group, Ascierto PA, Caracò C, Lissia A, Cossu A, Palmieri G, Italian Melanoma Intergroup (IMI).

Publikováno v: IMI Congresso 2020, online, 07-09/11/2020
info:cnr-pdr/source/autori:Colombino M, Rozzo C, Paliogiannis P, Casula M, Manca A, Doneddu V, Fedeli MA, Sini MC, Palomba G, Pisano M, Melanoma Unit of Sassari (MUS), Italian Association for Cancer Research (AIRC) Study Group, Ascierto PA, Caracò C, Lissia A, Cossu A, Palmieri G, Italian Melanoma Intergroup (IMI)./congresso_nome:IMI Congresso 2020/congresso_luogo:online/congresso_data:07-09%2F11%2F2020/anno:2020/pagina_da:/pagina_a:/intervallo_pagine

Malignant melanoma (MM) is one of the deadliest skin cancers. BRAF mutation testing plays a predominant role in the management of MM patients, because modern targeted therapies essentially consist of inhibitors of BRAF. BRAF V600 mutation must be det

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::3ea24a4e8cebd86648f139dface88782
http://www.cnr.it/prodotto/i/442941

Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)

Autor: Vanni, I., Casula, M., Pastorino, L., Manca, A., Dalmasso, B., Andreotti, V., Pisano, M., Colombino, M., Covre, A., Di Giacomo, A. M., Maio, M., De Logu, F., Massi, D., Portelli, F., Anichini, A., Mortarini, R., Bruno, W., Cabiddu, F., Spagnolo, F., Palomba, G., Sini, M. C., Fedeli, M. A., Lissia, A., Pfeffer, U., Tanda, E. T., Rozzo, C., Paliogiannis, P., Cossu, A., Ghiorzo, P., Palmieri, G., Caraco, C., Grimaldi, A. M., Ferraresi, V., Mandala, M., Patuzzo, R., Quaglino, P., Queirolo, P., Stanganelli, I.

Publikováno v: Diagnostic pathology 15 (2020): 15:1–15:18. doi:10.1186/s13000-020-01052-5
info:cnr-pdr/source/autori:Vanni I.; Casula M.; Pastorino L.; Manca A.; Dalmasso B.; Andreotti V.; Pisano M.; Colombino M.; Covre A.; Di Giacomo A.M.; Maio M.; De Logu F.; Massi D.; Portelli F.; Anichini A.; Mortarini R.; Bruno W.; Cabiddu F.; Spagnolo F.; Palomba G.; Sini M.C.; Fedeli M.A.; Lissia A.; Pfeffer U.; Tanda E.T.; Rozzo C.; Paliogiannis P.; Cossu A.; Ghiorzo P.; Palmieri G.; Caraco C.; Grimaldi A.M.; Ferraresi V.; Mandala M.; Patuzzo R.; Quaglino P.; Queirolo P.; Stanganelli I./titolo:Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)/doi:10.1186%2Fs13000-020-01052-5/rivista:Diagnostic pathology/anno:2020/pagina_da:15:1/pagina_a:15:18/intervallo_pagine:15:1–15:18/volume:15
Diagnostic Pathology
Diagnostic Pathology, Vol 15, Iss 1, Pp 1-18 (2020)

Background Identification of somatic mutations in key oncogenes in melanoma is important to lead the effective and efficient use of personalized anticancer treatment. Conventional methods focus on few genes per run and, therefore, are unable to scree

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a889b00808e9dee5c63628c220fdbde5
http://www.scopus.com/record/display.url?eid=2-s2.0-85097564294&origin=inward

The integrin alpha6/beta4 in epithelial and carcinoma cells

Autor: Quaranta, V, Collo, Luigia Rinalda, Rozzo, C, Starr, L, Gaietta, G, Tamura, Rn

Publikováno v: Integrins-The Biological Problems, edited by Yoshikazu Takada, pp. 177–196. Boca Raton: CRC press, 2017
info:cnr-pdr/source/autori:Vito Quaranta, Ginetta Collo, Carla Rozzo, Lisa Starr, Guido Gaietta, Richard.N. Tamura./titolo:The integrin alpha6%2Fbeta4 in epithelial and carcinoma cells./titolo_volume:Integrins-The Biological Problems/curatori_volume:Yoshikazu Takada/editore: /anno:2017

This book represents the most current, comprehensive, and authoritative study of integrins on the market today. It provides an overview of the diverse biological functions of integrins, including: The structure and functions of integrin cytoplasmic d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a68388eb846900b25d2d63ddb29f3f1f
https://publications.cnr.it/doc/446165

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

In vitro activity of the alfavbeta3 integrin antagonist RGDechi-hCit on malignant melanoma cells

Autor: Pisano M, de Paola I, Nieddu V, Sassu I, Cossu S, Galleri G, Del Gatto A, Budroni M, Cossu A, Saviano M, Palmieri G, Zaccaro L, Rozzo C

Publikováno v: Anticancer research 33 (2013): 871–879.
info:cnr-pdr/source/autori:Pisano M, de Paola I, Nieddu V, Sassu I, Cossu S, Galleri G, Del Gatto A, Budroni M, Cossu A, Saviano M, Palmieri G, Zaccaro L, Rozzo C/titolo:In vitro activity of the alfavbeta3 integrin antagonist RGDechi-hCit on malignant melanoma cells./doi:/rivista:Anticancer research/anno:2013/pagina_da:871/pagina_a:879/intervallo_pagine:871–879/volume:33

Background: In malignant melanoma (MM), overexpression of alfavbeta3 integrin is linked to a more metastatic phenotype. Development of anti-alfavbeta3 agents able to counteract melanoma progression would be helpful for disease treatment. A new select

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::b136f67910ffd167ae74da9560aa238b
http://www.cnr.it/prodotto/i/210925